DENNIS FAIR: Open Payments
NPI 1629074331 · STAFFORD, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,433 in 120 payments from 17 companies in 2025. Trend: 2023 $2,082 · 2024 $2,345 · 2025 $2,433
Food & beverage: $2,433
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 17 | $373 |
| Novo Nordisk Inc | 15 | $357 |
| Lilly USA, LLC | 13 | $333 |
| AstraZeneca Pharmaceuticals LP | 14 | $282 |
| ABBVIE INC. | 13 | $231 |
| Amgen Inc. | 14 | $199 |
| GlaxoSmithKline, LLC. | 9 | $184 |
| Abbott Laboratories | 6 | $130 |
| Astellas Pharma US Inc | 5 | $102 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $73 |
Products named: NURTEC ODT, MOUNJARO, AIRSUPRA, TRELEGY ELLIPTA, Ozempic, FREESTYLE LIBRE 3, Wegovy, QULIPTA.
Industry payments across VA — which companies pay providers there.
